Literature DB >> 7802521

Risk factors that attenuate the female coronary disease advantage.

W B Kannel1, P W Wilson.   

Abstract

OBJECTIVE: To compare the coronary disease experience of men and women in a community setting. DESIGN AND
SETTING: Prospective cohort study. PATIENTS: Long-term follow-up of a population-based sample of 5209 men and women.
RESULTS: Women outlive men and experience fewer cardiovascular events. By middle age, women lag 20 years behind men in the incidence of myocardial infarction, but the gap closes in the elderly, when cardiovascular disease becomes the leading cause of death in women as well as in men. Menopause promptly escalates coronary disease risk threefold and greatly erodes the advantage over men. Women and men share the same major risk factors for coronary disease, although women experience a lower absolute risk. However, high ratios of total/high-density lipoprotein cholesterol level ratios, left ventricular hypertrophy, and diabetes tend to eliminate the female advantage.
CONCLUSION: Coronary disease is not a minor problem in women. Consequently, women should take vigorous preventive measures. There is a need for particular attention to glucose tolerance and blood lipid levels and a greater sense of urgency when hypertension progresses to left ventricular hypertrophy.

Entities:  

Mesh:

Year:  1995        PMID: 7802521

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  66 in total

Review 1.  Postmenopausal hormone replacement therapy and atherosclerosis.

Authors:  Jennifer E Ho; Lori Mosca
Journal:  Curr Atheroscler Rep       Date:  2002-09       Impact factor: 5.113

Review 2.  Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

Authors:  Rachel Huxley; Federica Barzi; Mark Woodward
Journal:  BMJ       Date:  2005-12-21

3.  Risk factors associated with the incidence and progression of mitral annulus calcification: the multi-ethnic study of atherosclerosis.

Authors:  Sammy Elmariah; Matthew J Budoff; Joseph A C Delaney; Yasmin Hamirani; John Eng; Valentin Fuster; Richard A Kronmal; Jonathan L Halperin; Kevin D O'Brien
Journal:  Am Heart J       Date:  2013-09-26       Impact factor: 4.749

4.  Surgical menopause versus natural menopause and cardio-metabolic disturbances: A 12-year population-based cohort study.

Authors:  M Farahmand; F Ramezani Tehrani; M Bahri Khomami; M Noroozzadeh; F Azizi
Journal:  J Endocrinol Invest       Date:  2015-02-27       Impact factor: 4.256

Review 5.  The effects of oestrogens and their receptors on cardiometabolic health.

Authors:  Eugenia Morselli; Roberta S Santos; Alfredo Criollo; Michael D Nelson; Biff F Palmer; Deborah J Clegg
Journal:  Nat Rev Endocrinol       Date:  2017-03-17       Impact factor: 43.330

6.  Iron, inflammation and atherosclerosis risk in men vs. perimenopausal women.

Authors:  Subha V Raman; Travis P Sharkey-Toppen; Tam Tran; Jim X Liu; Beth McCarthy; Xin He; Suzanne Smart; Martha Gulati; Randell Wexler; Orlando P Simonetti; Rebecca D Jackson
Journal:  Atherosclerosis       Date:  2015-03-20       Impact factor: 5.162

7.  Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis.

Authors:  Shelley R Salpeter; Judith M E Walsh; Elizabeth Greyber; Edwin E Salpeter
Journal:  J Gen Intern Med       Date:  2006-04       Impact factor: 5.128

Review 8.  Obesity and cardiovascular disease in women.

Authors:  Camila Manrique-Acevedo; Bhavana Chinnakotla; Jaume Padilla; Luis A Martinez-Lemus; David Gozal
Journal:  Int J Obes (Lond)       Date:  2020-02-17       Impact factor: 5.095

9.  Estrogen delays the progression of salt-induced cardiac hypertrophy by influencing the renin-angiotensin system in heterozygous proANP gene-disrupted mice.

Authors:  S Jeson Sangaralingham; M Yat Tse; Stephen C Pang
Journal:  Mol Cell Biochem       Date:  2007-08-23       Impact factor: 3.396

10.  The role of rho kinase in sex-dependent vascular dysfunction in type 1 diabetes.

Authors:  Daniel W Nuno; Kathryn G Lamping
Journal:  Exp Diabetes Res       Date:  2010-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.